Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 P23

Bone

The reduction of bone mineral density in post-menopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH hormone secretion impairment

E Cecconi1, M Genovesi1, F Bogazzi1, L Grasso1, M Procopio2, C Marcocci1, A Pinchera1, L Bartalena3, E Martino1 & M Gasperi1


1Università di Pisa, Pisa, Italy; 2Università di Torino, Torino, Italy; 3Università dell’Insubria, Varese, Italy.


Primary hyperparathyroidism (PHP) and growth hormone deficiency (GHD) are both associated with alterations of bone metabolism.

GH secretion is frequently impaired in PHP patients; thus GH/IGF-I system alterations could be involved in the pathogenesis of osteoporosis.

In the present study 50 post-menopausal women with PHP were evaluated by GH response to GH-releasing hormone (GHRH)+arginine (ARG) test and femoral neck bone mineral density (BMD, g/cm2) by dual energy X-ray absorptiometry. BMI, serum ionised calcium, PTH and markers of bone remodelling (serum osteocalcin (OC), serum bone-specific alkaline phosphatase (B-AP), serum cross-laps (S-CTX) were evaluated as well.

Same data were collected in a group of 60 age-matched controls.

No difference was found between the two groups regarding age, age at menopause, BMI, serum ionised calcium, PTH and IGF-I concentrations.

GH secretion was reduced (mean GH response to GHRH+arg test: 8.8±4.2 μg/liter) in 34 patients and normal (28.7±11.8 μg/liter) in the remaining 16 (P<0.05), in the control group peak GH was 33.8±10.9 μg/liter.

Osteoporosis (T-score <−2.5) and osteopenia (T-score >−2.5 and <−1) were found in 73.5% and 17.6% of GHD patients, in 37.5% and 43.7% of patients with normal GH secretion and 3.1% and 27% of controls.

The prevalence of osteoporosis in GHD group was significantly different with respect to patients with normal GH secretion (P=0.02) and to controls (P=0.02).

T-score was not correlated with ionised calcium, nor with age, age at menopause or BMI, but was correlated with PTH serum levels in both groups and T-score was correlated with markers of bone remodelling only in GHD patients.

In conclusion, impairment of GH secretion could be involved as a pathogenetic factor in bone metabolism alterations of PHP.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.